Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q2 2024 call → NOWe need to determine if management describes successive engagements of the same kind coming in at progressively larger size. Look for statements about deal size, customer size, scope, etc. The transcript mentions a recent client win: a statewide park department requiring a comprehensive solution. That is an example of a larger, bundled offering. But does management convey that this is part of an upward drift in deal size versus their own past? They say "This is exactly the type of client the bundled capabilities of Sangoma can reach." They contrast with smaller vendors and larger vendors. They say "Client examples like this recent win offer higher MRR and NRR potential." But they don't explicitly compare to their own past deals. They talk about targeting more sophisticated mid-market clients, but that's an ambition. They say "we anticipate tapping into market segments" for fiscal 2025. That's future. They also say "a go-to-market adaptation of this scale will take time to ramp, and there'll be a lag before it delivers material results." So they are not saying that current deals are already larger than before. They are describing a strategy to move upmarket, but not that it's already happening with a pattern. The one example is a single win, but they don't frame it as part of an upward drift. They also mention "higher MRR and NRR potential" but that's potential. No explicit comparison to past deal sizes. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.